Your session is about to expire
← Back to Search
Hormone Therapy
Estrogen and Progesterone for Menopause Effects on Insulin Sensitivity
Phase 2
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
6 months to 3 years since cessation of menses
No surgically induced menopause
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is looking at the effect of estrogen and progesterone on insulin sensitivity in postmenopausal women.
Who is the study for?
This trial is for early postmenopausal women who are 6 months to 3 years since their last menstrual period. They should have a specific bone density score (BMD of 24-33) and must not have had menopause induced by surgery.Check my eligibility
What is being tested?
The study tests the effects of hormone replacement therapy on insulin sensitivity in postmenopausal women. It compares estrogen alone, estrogen with progestin, and placebo over a course of 16 weeks using various measures like glucose metabolism and muscle biopsy assessments.See study design
What are the potential side effects?
While the description doesn't list side effects, common ones from hormone replacement can include breast tenderness, headaches, nausea, mood changes, and blood clotting issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My last menstrual period was between 6 months and 3 years ago.
Select...
I have not had surgery to remove my ovaries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
2 Trials studying Menopause
15 Patients Enrolled for Menopause
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My last menstrual period was between 6 months and 3 years ago.I have not had surgery to remove my ovaries.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research open to adults of a certain age or older?
"According to the guidelines of this clinical trial, only individuals aged 45-55 are eligible for participation."
Answered by AI
What potential adverse effects may people experience from this treatment?
"Based on the available information, we have assigned a safety rating of 2 for this treatment as it is still in its second phase of clinical trials with limited data regarding efficacy."
Answered by AI
Share this study with friends
Copy Link
Messenger